Literature DB >> 24723099

Reasoning deficits among illicit drug users are associated with aspects of cannabis use.

John E Fisk1, Andy M Morley, Florentia Hadjiefthyvoulou, Catharine Montgomery.   

Abstract

Deficits in deductive reasoning have been observed among ecstasy/polydrug users. The present study seeks to investigate dose-related effects of specific drugs and whether these vary with the cognitive demands of the task. One hundred and five participants (mean age 21.33, SD 3.14; 77 females, 28 males) attempted to generate solutions for eight one-model syllogisms and one syllogism for which there was no valid conclusion. All of the one-model syllogisms generated at least one valid conclusion and six generated two valid conclusions. In these six cases, one of the conclusions was classified as common and the other as non-common. The number of valid common inferences was negatively associated with the aspects of short-term cannabis use and with measures of IQ. The outcomes observed were more than simple post-intoxication effects since cannabis use in the 10 days immediately before testing was unrelated to reasoning performance. Following adjustment for multiple comparisons, the number of non-common valid inferences was not significantly associated with any of the drug-use measures. Recent cannabis use appears to impair the processes associated with generating valid common inferences while not affecting the production of non-common inferences. It is possible, therefore, that the two types of inference may recruit different executive resources, which may differ in their susceptibility to cannabis-related effects.

Entities:  

Mesh:

Year:  2014        PMID: 24723099     DOI: 10.1007/s10339-014-0616-2

Source DB:  PubMed          Journal:  Cogn Process        ISSN: 1612-4782


  25 in total

1.  Dissociation of mechanisms underlying syllogistic reasoning.

Authors:  V Goel; C Buchel; C Frith; R J Dolan
Journal:  Neuroimage       Date:  2000-11       Impact factor: 6.556

2.  Theories of the syllogism: A meta-analysis.

Authors:  Sangeet Khemlani; P N Johnson-Laird
Journal:  Psychol Bull       Date:  2012-01-30       Impact factor: 17.737

3.  Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users.

Authors:  Leslie K Jacobsen; Kenneth R Pugh; Robert T Constable; Michael Westerveld; W Einar Mencl
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

4.  Neuropsychological consequences of alcohol and drug abuse on different components of executive functions.

Authors:  María José Fernández-Serrano; Miguel Pérez-García; Jacqueline Schmidt Río-Valle; Antonio Verdejo-García
Journal:  J Psychopharmacol       Date:  2009-12-09       Impact factor: 4.153

5.  The dynamics of deductive reasoning: an fMRI investigation.

Authors:  Diana Rodriguez-Moreno; Joy Hirsch
Journal:  Neuropsychologia       Date:  2008-09-13       Impact factor: 3.139

6.  Large scale brain activations predict reasoning profiles.

Authors:  Carlo Reverberi; Luca L Bonatti; Richard S J Frackowiak; Eraldo Paulesu; Paolo Cherubini; Emiliano Macaluso
Journal:  Neuroimage       Date:  2011-08-24       Impact factor: 6.556

7.  Hair MDMA samples are consistent with reported ecstasy use: findings from a study investigating effects of ecstasy on mood and memory.

Authors:  A B Scholey; L Owen; J Gates; J Rodgers; T Buchanan; J Ling; T Heffernan; P Swan; C Stough; A C Parrott
Journal:  Neuropsychobiology       Date:  2010-10-20       Impact factor: 2.328

8.  Syllogistic reasoning performance in MDMA (Ecstasy) users.

Authors:  Catharine Montgomery; John E Fisk; Russell Newcombe; Michelle Wareing; Philip N Murphy
Journal:  Exp Clin Psychopharmacol       Date:  2005-05       Impact factor: 3.157

9.  Everyday conditional reasoning: a working memory-dependent tradeoff between counterexample and likelihood use.

Authors:  Niki Verschueren; Walter Schaeken; Gery d'Ydewalle
Journal:  Mem Cognit       Date:  2005-01

10.  Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.

Authors:  F Indlekofer; M Piechatzek; M Daamen; C Glasmacher; R Lieb; H Pfister; O Tucha; K W Lange; H U Wittchen; C G Schütz
Journal:  J Psychopharmacol       Date:  2008-07-17       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.